Episode 126: The Future of Bioprinting With Cellink CEO Erik Gattenholm
It was our pleasure to talk with Erik this week about the company he founded/leads: Cellink. It is a high tech business within the biotechnology industry, so Ryan and I didn’t pretend to know the ins and outs of this business. But I thought it was a great listen for anyone who follows the industry. If interested, you can check-out our 25 stocks of Christmas episode with Trevor Muchedzi that also talks about the company.
Other topics this week for the back-half of the show: The Square/Afterpay merger, Trevor Milton getting charged with fraud, and the results of the Robinhood IPO.
Our Tuesday interview show is sponsored by 7investing. Use our link or enter promo code “CCM” at check-out to get $10 off your first month of the service.
Disclosure: The author and podcast guests are not your financial advisors. Ryan Henderson and Brett Schafer are general partners and portfolio managers at Arch Capital. Clients of Arch Capital may hold securities discussed on this show.